Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-14
2010-10-26
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S293000, C548S362500
Reexamination Certificate
active
07820683
ABSTRACT:
A quinazoline derivative of the Formula I:wherein the substituents are as defined in the text for use in the production of an anti-proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm-blooded animal such as man.
REFERENCES:
patent: 4322420 (1982-03-01), Kobayashi et al.
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 4640920 (1987-02-01), Boyle et al.
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 5405843 (1995-04-01), Fukazawa et al.
patent: 5721237 (1998-02-01), Myers et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5929080 (1999-07-01), Frost
patent: 5962458 (1999-10-01), Lohmann et al.
patent: 6004967 (1999-12-01), McMahon et al.
patent: 6046206 (2000-04-01), Pamukcu et al.
patent: 6117433 (2000-09-01), Edens et al.
patent: 6297258 (2001-10-01), Wissner et al.
patent: 6313130 (2001-11-01), Uckun et al.
patent: 6326373 (2001-12-01), Uckun et al.
patent: 6384223 (2002-05-01), Gletsos
patent: 6562319 (2003-05-01), Mishani et al.
patent: 6972288 (2005-12-01), Himmelsbach et al.
patent: 7148230 (2006-12-01), Bradbury et al.
patent: 2002/0082270 (2002-06-01), Himmelsbach et al.
patent: 2002/0128553 (2002-09-01), Mishani et al.
patent: 2003/0186995 (2003-10-01), Kath et al.
patent: 2004/0048880 (2004-03-01), Himmelsbach et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 2005/0043336 (2005-02-01), Hennequin et al.
patent: 2005/0054662 (2005-03-01), Hennequin et al.
patent: 2005/0215574 (2005-09-01), Bradbury et al.
patent: 2006/0211714 (2006-09-01), Hennequin et al.
patent: 2006/0287295 (2006-12-01), Barlaam et al.
patent: 2007/0015743 (2007-01-01), Bradbury et al.
patent: 2007/0032508 (2007-02-01), Bradbury et al.
patent: 2007/0032513 (2007-02-01), Hennequin et al.
patent: 2007/0037837 (2007-02-01), Hennequin et al.
patent: 2007/0043009 (2007-02-01), Hennequin et al.
patent: 2007/0043010 (2007-02-01), Bradbury et al.
patent: 2007/0082921 (2007-04-01), Hennequin et al.
patent: 2007/0088044 (2007-04-01), Hennequin et al.
patent: 2007/0099943 (2007-05-01), Bradbury et al.
patent: 2007/0149546 (2007-06-01), Bradbury et al.
patent: 2007/0232607 (2007-10-01), Bradbury et al.
patent: 2007/0244136 (2007-10-01), Hennequin et al.
patent: 2007/0293490 (2007-12-01), Delouvrie et al.
patent: 2476008 (2003-10-01), None
patent: 2543649 (2005-05-01), None
patent: 0288563 (1988-11-01), None
patent: 0566226 (1995-11-01), None
patent: 0602851 (1996-10-01), None
patent: 0520722 (1996-12-01), None
patent: 0787722 (1997-08-01), None
patent: 0837063 (1998-04-01), None
patent: 0326330 (2002-07-01), None
patent: 1230919 (2002-08-01), None
patent: 1369418 (2003-12-01), None
patent: 2295387 (1996-05-01), None
patent: 08-003144 (1996-01-01), None
patent: 11-189586 (1999-07-01), None
patent: WO 88/02365 (1988-04-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO 93/08170 (1993-04-01), None
patent: WO 93/17682 (1993-09-01), None
patent: WO 95/15758 (1995-06-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/15118 (1996-05-01), None
patent: WO 96/16960 (1996-06-01), None
patent: WO 96/30347 (1996-10-01), None
patent: WO 96/33977 (1996-10-01), None
patent: WO 96/33978 (1996-10-01), None
patent: WO 96/33979 (1996-10-01), None
patent: WO 96/33980 (1996-10-01), None
patent: WO 96/33981 (1996-10-01), None
patent: WO 96/39145 (1996-12-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 97/11692 (1997-04-01), None
patent: WO 97/13771 (1997-04-01), None
patent: WO 97/22596 (1997-06-01), None
patent: WO 97/30034 (1997-08-01), None
patent: WO 97/30035 (1997-08-01), None
patent: WO 97/30044 (1997-08-01), None
patent: WO 97/38983 (1997-10-01), None
patent: WO 97/38994 (1997-10-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/02437 (1998-01-01), None
patent: WO 98/02438 (1998-01-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 98/38984 (1998-09-01), None
patent: WO 98/50038 (1998-11-01), None
patent: WO 98/50370 (1998-11-01), None
patent: WO 99/06378 (1999-02-01), None
patent: WO 99/09016 (1999-02-01), None
patent: WO 99/24037 (1999-05-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 99/61428 (1999-12-01), None
patent: WO 00/00202 (2000-01-01), None
patent: WO 00/06555 (2000-02-01), None
patent: WO 00/09481 (2000-02-01), None
patent: WO 00/10981 (2000-03-01), None
patent: WO 00/18740 (2000-04-01), None
patent: WO 00/20402 (2000-04-01), None
patent: WO 00/24718 (2000-05-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 00/51587 (2000-09-01), None
patent: WO 00/51991 (2000-09-01), None
patent: WO 00/55141 (2000-09-01), None
patent: WO 00/73260 (2000-12-01), None
patent: WO 01/07432 (2001-02-01), None
patent: WO 01/12227 (2001-02-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21595 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/32632 (2001-05-01), None
patent: WO 01/45641 (2001-06-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 01/94341 (2001-12-01), None
patent: WO 01/98277 (2001-12-01), None
patent: WO 02/18372 (2002-03-01), None
patent: WO 02/24684 (2002-03-01), None
patent: WO 02/30924 (2002-04-01), None
patent: WO 02/34744 (2002-05-01), None
patent: WO 02/41882 (2002-05-01), None
patent: WO 02/44166 (2002-06-01), None
patent: WO 02/48117 (2002-06-01), None
patent: WO 02/056882 (2002-07-01), None
patent: WO 02/062767 (2002-08-01), None
patent: WO 02/066445 (2002-08-01), None
patent: WO 02/068409 (2002-09-01), None
patent: WO 02/073235 (2002-09-01), None
patent: WO 02/076976 (2002-10-01), None
patent: WO 02/092577 (2002-11-01), None
patent: WO 02/092578 (2002-11-01), None
patent: WO 02/094790 (2002-11-01), None
patent: WO 03/040108 (2003-05-01), None
patent: WO 03/040109 (2003-05-01), None
patent: WO 03/049740 (2003-06-01), None
patent: WO 03/082290 (2003-10-01), None
patent: WO 03/082831 (2003-10-01), None
patent: WO 2004/006846 (2004-01-01), None
patent: WO 2004/046101 (2004-06-01), None
patent: WO 2004/064718 (2004-08-01), None
patent: WO 2004/093880 (2004-11-01), None
patent: WO 2004/096226 (2004-11-01), None
patent: WO 2005/012290 (2005-02-01), None
patent: WO 2005/013998 (2005-02-01), None
patent: WO 2005/026150 (2005-03-01), None
patent: WO 2005/026151 (2005-03-01), None
patent: WO 2005/026152 (2005-03-01), None
patent: WO 2005/026156 (2005-03-01), None
patent: WO 2005/026157 (2005-03-01), None
patent: WO 2005/028469 (2005-03-01), None
patent: WO 2005/028470 (2005-03-01), None
patent: WO 2005/030757 (2005-03-01), None
patent: WO 2005/030765 (2005-04-01), None
patent: WO 2005/051923 (2005-05-01), None
patent: WO 2005/051923 (2005-06-01), None
patent: WO 2005/075439 (2005-08-01), None
patent: WO 2005/097134 (2005-10-01), None
patent: WO 2005/118572 (2005-12-01), None
patent: WO 2006/008526 (2006-01-01), None
patent: WO 2006/064196 (2006-06-01), None
patent: WO 2006/090163 (2006-08-01), None
patent: WO 2006/092573 (2006-09-01), None
patent: WO 2006/092574 (2006-09-01), None
patent: WO 2006/117521 (2006-11-01), None
patent: WO 2006/117523 (2006-11-01), None
patent: WO 2007/034143 (2007-03-01), None
patent: WO 2007/063291 (2007-06-01), None
patent: WO 2007/063293 (2007-06-01), None
Ballard et al. “Developing a small molecule erbB2 inhibitor:challenges with optimising DMPK properties” Poster—Presented at DMDG Cambridge (Feb. 6, 2008).
Barlaam et al. “Indazolylamino/Anilinoquinazolines Bearing a C-5 Substitution as erbB2 Kinase Inhibitors: Structure-Activity Relationships and Identification of a Candidate Drug” Poster No. P044, presented at XXth International Symposium on Medicinal Chemistry (EFMC-ISMC 2008), Vienna, Austria, Aug. 31-Sep. 4, 2008.
Barlaam et al. “Indazolylamino/Anilinoquinazolines Bearing a C-5 substitution as erbB2 kinase inhibitors: Structure-activity relationships and identification of a candidate drug” at AACR in 2007.
Grunwald et al. “Developing inhibitors of the epidermal growth factor receptor for cance
Barlaam Bernard Christophe
Bradbury Robert Hugh
Ducray Richard
AstraZeneca AB
McDowell Brian
Wilson James O
LandOfFree
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4180683